Ceo
CurrentRenovion is a clinical stage pharmaceutical company with a nebulized therapy for chronic inflammatory airway diseases – Arina-1. Our goal is to be the first and only drug approved for lung transplant patients. Our clinical plan is to seek approval for patients in other therapeutic areas such as cystic fibrosis, non-cf bronchiectasis and other patient.